Mechanisms of disease: Fibroblasts - A new look at an old problem

Nature Clinical Practice Nephrology

Volumn 2, Issue 2, 2006, Pages 101-108

  Neilson, Eric G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial mesenchymal transition; Fibroblasts; Fibrosis; FSP1; Kidney

Indexed keywords

CELL PROTEIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST SPECIFIC PROTEIN 1; IMATINIB; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CELL ACTIVATION; CELL SURFACE; ENDOTHELIUM INJURY; ENZYME ACTIVITY; EPITHELIUM CELL; FIBROBLAST; GASTRULATION; GLOMERULUS FILTRATION; HUMAN; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PARENCHYMA; MESENCHYME CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; REVIEW; SMOOTH MUSCLE FIBER;

CELL PROLIFERATION; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; PROTEINURIA;

EID: 33644830593     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0093     Document Type: Review

References (70)

1. Iwano M and Neilson EG (2004) Mechanisms of tubule-interstitial fibrosis. Curr Opin Nephrol Hypertens 13: 279-284
2. Harris RC and Neilson EG: Towards a unified hypothesis of renal progression. Ann Rev Med, in press
3. Strutz F and Neilson EG (2003) New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 24: 459-476
4. Iwano M et al. (2001) Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther 3: 149-159
5. Kalluri R and Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784
6. Shook D and Keller R (2003) Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 120: 1351-1383
7. Karihaloo A et al. (2005) Signals which build a tubule. Nephron Exp Nephrol 100: e40-45
8. Barasch J et al. (1999) Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell 99: 377-386
9. Oliver JA et al. (2004) The renal papilla is a niche for adult kidney stem cells. J Clin Invest 114: 795-804
10. Lin F et al. (2005) Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115: 1756-1764
11. Strutz F et al. (1995) Identification and characterization of a f ibroblast marker: FSP1. J Cell Biol 130: 393-405
12. Iwano M et al. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350
13. Alvarez RJ et al. (1992) Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 41: 14-23
14. Zeisberg M et al. (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968
15. Liu Y (2004) Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 287: F7-F16
16. Zeisberg M and Kalluri R (2004) The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 82: 175-181
17. Abe R et al. (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166: 7556-7562
18. Faulkner JL et al. (2005) Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol 167: 1193-1205
19. Leung EW et al. (2000) Extracellular matrix components in retrocorneal fibrous membrane in comparison to corneal endothelium and Descemets membrane. Mol Vis 6: 15-23
20. Neilson EG (2005) Setting a trap for tissue fibrosis. Nat Med 11: 373-374
21. Strutz F et al. (2002) Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61: 1714-1728
22. Okada H et al. (1997) The early role of FSP1 in epithelial-mesenchymal transformation. Am J Physiol 273: 563-574
23. Stachowiak MK et al. (2003) Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation. J Cell Biochem 90: 662-691
24. Shi Y and Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700
25. Sato M et al. (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112: 1486-1494
26. Kim K et al. (2002) Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26: 463-476
27. Labbe E et al. (2000) Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA 97: 8358-8363
28. Hussein SM et al. (2003) Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278: 48805-48814
29. Yang J et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cel 117: 927-939
30. Nieto MA (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166
31. Okada H et al. (2000) Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 58: 587-597
32. Boccaccio C et al. (1998) Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391: 285-288
33. Yang J and Liu Y (2002) Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96-107
34. Wang S et al. (2003) Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63: 2037-2049
35. Morrissey J et al. (2002) Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13 (Suppl 1): S14-S21
36. Hu MC and Rosenblum ND (2005) Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development 132: 215-225
37. Bonner JC (2004) Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15: 255-273
38. Balemans W and Van Hul W (2002) Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250: 231-250
39. Border WA et al. (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364
40. Abreu JG et al. (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4: 599-604
41. Lin J et al. (2005) Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med 11: 387-393
42. Yee J et al. (1991) Tubulointerstitial injury following glomerulonephritis. Semin Nephrol 11: 361-366
43. Kriz W (2002) Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 57: 189-195
44. Brenner BM (2002) Remission of renal disease: recounting the challenge, acquiring the goal. J Clin Invest 110: 1753-1758
45. Perico N et al. (2005) Pathophysiology of disease progression in proteinuric nephropathies. Kidney Int Suppl: S79-S82
46. Eppel GA et al. (1999) The return of glomerular-filtered albumin to the rat renal vein. Kidney Int 55: 1861-1870
47. Hirschberg R and Wang S (2005) Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease. Curr Opin Nephrol Hypertens 14: 43-52
48. Donadelli R et al. (2000) Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 36: 1226-1241
49. 2 through a PKC-dependent pathway. J Am Soc Nephrol 13: 1179-1189
50. Zoja C et al. (1998) Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int 53: 1608-1615
51. Iglesias J and Levine JS (2001) Albuminuria and renal injury - beware of proteins bearing gifts. Nephrol Dial Transplant 16: 215-218
52. Kees-Folts D et al. (1994) Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 45: 1697-1709
53. Wang SN et al. (1999) Glomerular Ultrafiltration and apical tubular action of IGF-I, TGF-beta, and HGF in nephrotic syndrome. Kidney Int 56: 1247-1251
54. Wolf G and Ritz E (2005) Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 67: 799-812
55. Cao Z and Cooper ME (2001) Role of angiotensin II in tubulointerstitial injury. Semin Nephrol 21: 554-562
56. Wolf G et al. (2004) Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells. Kidney Int 66: 1849-1858
57. Anders HJ et al. (2003) Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63: 401-415
58. Klahr S and Morrissey J J (1998) The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy. Semin Nephrol 18: 622-632
59. Chiurchiu C et al. (2005) Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses. J Am Soc Nephrol 16 (Suppl 1): S58-S63
60. Lewis EJ and Lewis JB (2004) ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner? J Am Soc Nephrol 15: 1358-1360
61. Moses HL et al. (1987) Transforming growth factor beta regulation of cell proliferation. J Cell Physiol (Suppl 5): S1-S7
62. Fujigaki Y et al. (2001) Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats. Virchows Arch 439: 35-45
63. Moustakas A et al. (2002) Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 82: 85-91
64. Takahashi E et al. (2004) Snail regulates p21 (WAF/ CIP1) expression in cooperation with E2A and Twist. Biochem Biophys Res Commun 325: 1136-1144
65. Tang WW et al. (1996) Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148: 1169-1180
66. Satoh T et al. (1993) Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types. Mol Cell Biol 13: 3706-3713
67. Espada J et al. (1999) H-Ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J Cell Biol 146: 967-980
68. Levitzki A (2004) PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases. Cytokine Growth Factor Rev 15: 229-235
69. Mezzano SA et al. (2001) Angiotensin II and renal fibrosis. Hypertension 38: 635-638
70. Strutz F (2001) Potential methods to prevent interstitial fibrosis in renal disease. Expert Opin Investig Drugs 10: 1989-2001